ArticleFrontiers in pharmacology2025

Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes.

Seungchan Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.